Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

China’s WuXi Starts Venture Capital Fund

by Jean-François Tremblay
November 21, 2011 | A version of this story appeared in Volume 89, Issue 47

WuXi PharmaTech, a Chinese contract research and manufacturing firm, has formed a $50 million venture capital fund. The Shanghai-based contractor hopes to profit both from the capital appreciation of the companies it invests in and by accessing technology they develop. “This fund will invest in technologies and life sciences companies to enhance our platform capabilities and to help great minds realize the potential of their technologies and intellectual property,” says WuXi CEO Ge Li.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.